![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 01, 2024 11:03:18 AM
<<<<<<<<<< the difference in performance between the Actipatch & Recovery RX >>>>>>>>>>>
Having two separate names allowed different marketing strategies for Retail and Medical Professional use.
BIEL is claiming a 50% power increase for the new Surgical Incision RecoveryRx which would give it a definite advantage over the ActiPatch for healing after surgery. It is likely this power increase was achieved by focusing the device's power, by use of an elongated rectangular shaped antenna, directly on the surgical incision. This method of increasing the power, with an unchanged power supply, should result in a simpler FDA Clearance.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM